Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Jörg Janne Vehreschild
© MedizinFotoKöln/Dorothea Hensen

Doctor and data guru at the DZIF

Jörg Janne Vehreschild started his professional career as a programmer. However, he soon decided to pursue his second passion and began his medical studies a year later. Today, at only 39, Vehreschild

Pseudomonas aeruginosa bacteria are extremely robust and resilient and can dwell in virtually any habitat
© HZI/Manfred Rohde

New inhibitor for persistent bacterial biofilms

Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in

Dr Silvia Portugal heads a DZIF junior research group in Heidelberg
© Universitätsklinikum Heidelberg

1.5 million euros for malaria research

Dr Silvia Portugal, Head of a DZIF junior research group, has received 1.5 million euros’ funding from the European Research Council. At the Heidelberg University Hospital, together with an

The chemical structure of newly discovered antibiotic Lugdunin. Also in the photograph: the two lead authors Alexander Zipperer (left) and Martin Christoph Konnerth (right)
© Foto: Martin Christoph Konnerth

DZIF team from Tübingen receives Rudolf Schülke Foundation’s Hygiene Prize

This year, the Rudolf Schülke Foundation awarded its renowned Hygiene Prize worth 15,000 € to a DZIF research team led by Dr Bernhard Krismer, Prof Andreas Peschel and Dr Alexander Zipperer from the

Zika virus particles (red)
© cdc/Cynthia Goldsmith

How reliable is diagnostic testing for Zika?

Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country. DZIF scientists from the

CERMEL Director Bertrand Lell
© Universitätsklinikum Tübingen

New process allows tailor-made malaria research

Scientists at the Institute of Tropical Medicine of the University of Tübingen, the German Center for Infection Research (DZIF), and of Sanaria Inc. have developed an infection system that allows

Corallopyronin A inhibits intracellular growth of Orientia tsutsugamushi.
© 2018 American Society for Microbiology

New antibiotic against the Tsutsugamushi disease pathogen discovered

Tsutsugamushi fever, or “scrub typhus”, is an infectious disease related to typhus, which is endemic in large parts of Asia. The disease has an estimated incidence of approximately one million cases

Every step is precisely monitored in clinical trials.
© MedizinFoto Köln

Improving pneumonia protection for dialysis patients

The first joint study to be conducted across all twelve clinical trial units at the German Center for Infection Research (DZIF) has been initiated. The aim of the study is to improve vaccine

The digitally-colorized scanning electron microscopic (SEM) image depicts numerous filamentous Ebola virus particles (blue) budding from a chronically-infected cell.
© National Institute of Allergy and Infectious Diseases

European research team outwits Ebola virus

An artificially produced inhibitor curbs Ebola virus replication and could be used to develop drugs for life-threatening Ebola virus epidemics. An European team of scientists bases this hope on

The outbreak strain could be conclusively confirmed by genome analysis
© DZIF/scienceRELATIONS

Genome analysis confirms Europe-wide multidrug-resistant tuberculosis outbreak

The National Reference Center at the Research Center Borstel has confirmed a Europe-wide outbreak of a multidrug-resistant Mycobacterium tuberculosis strain in 29 refugees from the Horn of Africa. The